Pathogenic Variants in Mennonites From Southern Brazil: Implications for Preventive Measures in Public Health
Clinical Genetics · 2026
DOI: 10.1111/cge.70035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, 2026. Verfasst von Luiza Beatriz Mayer de Lima und 8 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Internal Medicine, Federal University of Paraná (UFPR), Curitiba, Brazil. Hauptthemen laut MEDLINE: Genetic Predisposition to Disease. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação Araucária, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Empresa Brasileira de Serviços Hospitalares (EBSerH).
Abstract (Originalsprache)
The Mennonite population has a unique history of 500 years of genetic isolation shaped by at least three demographic bottlenecks, founder effects, inbreeding, epidemics, and migrations. To evaluate their susceptibility for monogenic diseases (MD), we performed whole‐exome sequencing on 325 volunteers from two South Brazilian Mennonite settlements (one urban and another rural). We identified 23 pathogenic variants (P) and 27 likely P, with 22.8% accounting for endocrine, nutritional, and metabolic MDs, 17.5% for developmental anomalies, and 10.5% for nervous system MDs. HFE rs1800562 causing hereditary hemochromatosis presented the highest frequency (7.54%), followed by BTD rs13078881 for biotinidase deficiency (7.08%), FLG rs61816761 for ichthyosis vulgaris and atopic dermatitis (3.38%), and FANCM rs147021911 for Fanconi anemia (3.08%). Genomic and genealogical analysis confirmed their European origin, with very low consanguinity and high heterozygosity coefficients, confirming a random selection of refugees that emigrated from widespread settlements in Russia to Brazil in 1930. There was also a slight deviation to Native Americans for self‐reported admixed Mennonites. Even so, founder effects occurred for 96% of P, whose frequencies differed from non‐Finnish Europeans, Amish, and Brazilian populations. These findings highlight the genetic risks in this population, reinforcing the importance of genetic counseling, screening programs, and Personalized and Preventive Medicine strategies to mitigate health risks associated with inherited conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Postgraduate Program in Internal Medicine, Federal University of Paraná (UFPR), Curitiba, Brazil.
- Laboratory of Human Molecular Genetics, Department of Genetics, Federal University of Paraná (UFPR), Curitiba, Brazil.
- Human Genetics Branch, National Institute of Mental Health, Bethesda, Maryland, USA.
- Regeneron Genetics Center, Tarrytown, New York, USA.
ORCID-Profile: Isabela Dall'Oglio Bucco, Valéria Bumiller-Bini Hoch, Angelica Beate Winter Boldt
Förderung
- Fundação Araucária
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Empresa Brasileira de Serviços Hospitalares (EBSerH)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Mayer de Lima, L. B., Auer, E. D., Dall'Oglio Bucco, I., Hoch, V. B., Dos Santos, P. I., Lopes, F. L., Shuldiner, A., Júnior, E. L., & Boldt, A. B. W. (2026). Pathogenic Variants in Mennonites From Southern Brazil: Implications for Preventive Measures in Public Health. Clinical Genetics. https://doi.org/10.1111/cge.70035
Vancouver
Mayer de Lima LB, Auer ED, Dall'Oglio Bucco I, Hoch VB, Dos Santos PI, Lopes FL, et al. Pathogenic Variants in Mennonites From Southern Brazil: Implications for Preventive Measures in Public Health. Clinical Genetics. 2026. doi:10.1111/cge.70035
BibTeX
@article{MayerdeLima2026,
author = {Mayer de Lima, Luiza Beatriz and Auer, Eduardo Delabio and Dall'Oglio Bucco, Isabela and Hoch, Valéria Bumiller-Bini and Dos Santos, Priscila Ianzen and Lopes, Fabiana L and Shuldiner, Alan and Júnior, Emilton Lima and Boldt, Angelica Beate Winter},
title = {Pathogenic Variants in Mennonites From Southern Brazil: Implications for Preventive Measures in Public Health},
journal = {Clinical Genetics},
year = {2026},
doi = {10.1111/cge.70035}
}
EUVIMED